Edgestream Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.25M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.47M | Sell |
|
|||||
|
2024
Q1 | $3.49M | Buy |
|
|||||
|
2023
Q4 | $1.52M | Buy |
|
|||||
|
2023
Q3 | $429K | Sell |
|
|||||
|
2023
Q2 | $2.19M | Buy |
|
|||||
|
2023
Q1 | $1.54M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.57M | Buy |
|
|||||
|
2022
Q1 | $653K | Sell |
|
|||||
|
2021
Q4 | $3.73M | Buy |
|
|||||
|
2021
Q3 | $3.1M | Buy |
|
|||||
|
2021
Q2 | $1.98M | Buy |
|